esophageal cancer

Barrett’s esophagus is considered a precancerous condition, however the vast majority of people with the condition do not develop cancer.

As a sports and news photojournalist for a Buffalo television station, J.T. Messinger is used to seeing the world through a camera lens.

“Roswell Park is at the forefront of research on gastroesophageal cancer, and these studies are aiming to improve the efficacy of chemotherapy, immunotherapy and radiation in patients.”
“I was given a choice to see a doctor at another facility, but because of what I know about my wife’s work and the cutting- edge research and treatment at Roswell Park, of course I went to Roswell Park.”
If the patient’s cancer didn’t respond to chemotherapy and radiation, options were limited other than a wait-and-see approach. But new research has found that the introduction of an immunotherapy medication can dramatically improve their response. 
Christos Fountzilas, MD, Associate Professor of Oncology and board-certified gastrointestinal medical oncologist at Roswell Park Comprehensive Cancer Center, answers some of the most common questions about this rare and complex type of cancer.